These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4086916)

  • 1. Chromosomal aberrations in cultures of skin fibroblasts of leprosy patients.
    Hackel C; Beiguelman B
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):533-9. PubMed ID: 4086916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal study of human age-related chromosomal analysis in skin fibroblasts.
    Mukherjee AB; Thomas S
    Exp Cell Res; 1997 Aug; 235(1):161-9. PubMed ID: 9281365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
    Mahapatra SB; Ramu G
    Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy.
    Hendrick SS; Wilkin JK
    Am Fam Physician; 1982 Nov; 26(5):161-6. PubMed ID: 7148625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
    Haimanot RT; Mshana RN; McDougall AC; Andersen JG
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dimorphous leprosy].
    Esca SA; Zelger J
    Hautarzt; 1984 Jun; 35(6):298-302. PubMed ID: 6469634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muramidase (lysozyme) findings in sural and radial nerve biopsies in leprosy patients after varying periods of treatment.
    Haimanot RT; McDougall AC; Mshana RN; Andersen JG; Belehu A
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):238-46. PubMed ID: 4020211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage studies in untreated and treated leprosy patients.
    Gandhi G; Singh B
    Mutagenesis; 2004 Nov; 19(6):483-8. PubMed ID: 15548761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 6000 skin biopsies of the national leprosy control program in Mexico.
    Vargas-Ocampo F
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):427-36. PubMed ID: 15755197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
    Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological study of apparently normal skin of patients with leprosy.
    El-Darouti MA; Hussein S; Marzouk SA; Nabil N; Hunter NS; Mahgoub D; El-Eishi NH; Abdel-Halim MR
    Int J Dermatol; 2006 Mar; 45(3):292-6. PubMed ID: 16533232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral zinc as an adjunct to dapsone in lepromatous leprosy.
    Mathur NK; Bumb RA; Mangal HN; Sharma ML
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):331-8. PubMed ID: 6541200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.